Tech Company Financing Transactions

Antera Therapeutics Funding Round

Antera Therapeutics, based in Boston, secured $1.7 million from RA Capital and private investors.

Transaction Overview

Announced On
6/2/2016
Transaction Type
Venture Equity
Amount
$1,700,000
Round
Seed
Investors

RA Capital (Lead Investor)

Private Investors (Gil Omenn)

Private Investors (Joe Gentile)

Private Investors (Martin Madaus)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
125 Western Ave.
Boston, MA 02134
USA
Email Address
Overview
Aralyte is an all-natural, organic food for special dietary use that makes getting your child 6g of peanut protein per week easy.
Profile
Antera Therapeutics LinkedIn Company Profile
Social Media
Antera Therapeutics Company Twitter Account
Company News
Antera Therapeutics News
Facebook
Antera Therapeutics on Facebook
YouTube
Antera Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Clarence Friedman
  Clarence Friedman LinkedIn Profile  Clarence Friedman Twitter Account  Clarence Friedman News  Clarence Friedman on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/2/2016: theSkimm venture capital transaction
Next: 6/2/2016: Tile venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary